Cargando…
Open science approaches to COVID-19
In only a matter of months, the coronavirus disease of 2019 (COVID-19) has spread around the world. The global impact of the disease has caused significant and repeated calls for quick action towards new medicines and vaccines. In response, researchers have adopted open science methods to begin to c...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590891/ https://www.ncbi.nlm.nih.gov/pubmed/33145011 http://dx.doi.org/10.12688/f1000research.26084.1 |
_version_ | 1783600885758164992 |
---|---|
author | Tse, Edwin G. Klug, Dana M. Todd, Matthew H. |
author_facet | Tse, Edwin G. Klug, Dana M. Todd, Matthew H. |
author_sort | Tse, Edwin G. |
collection | PubMed |
description | In only a matter of months, the coronavirus disease of 2019 (COVID-19) has spread around the world. The global impact of the disease has caused significant and repeated calls for quick action towards new medicines and vaccines. In response, researchers have adopted open science methods to begin to combat this disease via global collaborative efforts. We summarise here some of those initiatives, and have created an updateable list to which others may be added. Though open science has previously been shown as an accelerator of biomedical research, the COVID-19 crisis has made openness seem the logical choice. Will openness persist in the discovery of new medicines, after the crisis has receded? |
format | Online Article Text |
id | pubmed-7590891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-75908912020-11-02 Open science approaches to COVID-19 Tse, Edwin G. Klug, Dana M. Todd, Matthew H. F1000Res Review In only a matter of months, the coronavirus disease of 2019 (COVID-19) has spread around the world. The global impact of the disease has caused significant and repeated calls for quick action towards new medicines and vaccines. In response, researchers have adopted open science methods to begin to combat this disease via global collaborative efforts. We summarise here some of those initiatives, and have created an updateable list to which others may be added. Though open science has previously been shown as an accelerator of biomedical research, the COVID-19 crisis has made openness seem the logical choice. Will openness persist in the discovery of new medicines, after the crisis has receded? F1000 Research Limited 2020-08-25 /pmc/articles/PMC7590891/ /pubmed/33145011 http://dx.doi.org/10.12688/f1000research.26084.1 Text en Copyright: © 2020 Tse EG et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Tse, Edwin G. Klug, Dana M. Todd, Matthew H. Open science approaches to COVID-19 |
title | Open science approaches to COVID-19 |
title_full | Open science approaches to COVID-19 |
title_fullStr | Open science approaches to COVID-19 |
title_full_unstemmed | Open science approaches to COVID-19 |
title_short | Open science approaches to COVID-19 |
title_sort | open science approaches to covid-19 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590891/ https://www.ncbi.nlm.nih.gov/pubmed/33145011 http://dx.doi.org/10.12688/f1000research.26084.1 |
work_keys_str_mv | AT tseedwing openscienceapproachestocovid19 AT klugdanam openscienceapproachestocovid19 AT toddmatthewh openscienceapproachestocovid19 |